Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter

NCT00421421 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

276

Enrollment

INDUSTRY

Sponsor class

Stopped Incomplete information

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Dutasteride

Sponsor

GlaxoSmithKline